» Articles » PMID: 3864171

Inhibitory Action of Quercetin on Xanthine Oxidase and Xanthine Dehydrogenase Activity

Overview
Specialty Pharmacology
Date 1985 Sep 1
PMID 3864171
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Quercetin is an equally good inhibitor of xanthine oxidase (type O, oxygen-reducing enzyme) and xanthine dehydrogenase (type D, NAD+-reducing enzyme) activity of a preparation of the xanthine-oxidizing enzyme partially purified from rat liver. The inhibition seems competitive with the oxidase form and non-competitive (mixed-type) with the dehydrogenase form of the enzyme. These inhibitory properties should be referred to the flavonoid structure of quercetin rather than to its antioxidant power. The antioxidant properties of quercetin and its inhibitory effect on the xanthine-oxidizing enzyme are discussed with reference to hyperuricemic and ischemic states.

Citing Articles

Unveiling the Emerging Role of Xanthine Oxidase in Acute Pancreatitis: Beyond Reactive Oxygen Species.

Han C, Wu Y, Rong J, Xia Q, Du D Antioxidants (Basel). 2025; 14(1).

PMID: 39857429 PMC: 11759826. DOI: 10.3390/antiox14010095.


Quercetin as a Modulator of PTPN22 Phosphomonoesterase Activity: A Biochemical and Computational Evaluation.

Sulyman A, Yusuf T, Aribisala J, Ibrahim K, Ajani E, Ajiboye A Curr Issues Mol Biol. 2024; 46(10):11156-11175.

PMID: 39451542 PMC: 11506171. DOI: 10.3390/cimb46100662.


Mechanism and use strategy of uric acid-lowering drugs on coronary heart disease.

Cai R, Li F, Li Y, Li Y, Peng W, Zhao M Int J Cardiol Heart Vasc. 2024; 53:101434.

PMID: 38974459 PMC: 11225710. DOI: 10.1016/j.ijcha.2024.101434.


Design, synthesis, and evaluation of benzofuran-based chromenochalcones for antihyperglycemic and antidyslipidemic activities.

Korthikunta V, Singh R, Srivastava R, Pandey J, Srivastava A, Chaturvedi U RSC Med Chem. 2023; 14(3):470-481.

PMID: 36970150 PMC: 10033782. DOI: 10.1039/d2md00341d.


Quercetin as a JAK-STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases.

Zalpoor H, Nabi-Afjadi M, Forghaniesfidvajani R, Tavakol C, Farahighasreaboonasr F, Pakizeh F Cell Mol Biol Lett. 2022; 27(1):60.

PMID: 35883021 PMC: 9327369. DOI: 10.1186/s11658-022-00355-3.